Welcome

The Liverpool NIHR Biomedical Research Unit in Pancreatic Disease is based at the Royal Liverpool University Hospital. It is a leading global translational research unit dedicated to the management of pancreatic digestive diseases, such as acute and chronic pancreatitis and pancreatic cancer. The Liverpool NIHR Biomedical Research Unit in Pancreatic Disease is the premier centre in the UK and one of the top three centres in Europe, carrying out translational research into pancreatitis and pancreatic cancer.

The BRU was set up in 2008 by Professor Robert Sutton and his research team, following an award from the National Institute of Health Research (NIHR) to a partnership between the Royal Liverpool and Broadgreen University Hospitals NHS Trust (RLBUHT) and the University of Liverpool.

The BRU is built around the world class excellence of pancreatic research in Liverpool, and has a range of collaborations with other leading European research institutions. The BRU also works with companies to develop and validate a broad range of health care products including new therapeutics and diagnostic methodologies, and has started research forums with the aim of developing new mutually beneficial collaborations.